Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 1:12:837257.
doi: 10.3389/fonc.2022.837257. eCollection 2022.

Preoperative Prediction Power of Radiomics for Breast Cancer: A Systemic Review and Meta-Analysis

Affiliations

Preoperative Prediction Power of Radiomics for Breast Cancer: A Systemic Review and Meta-Analysis

Zhenkai Li et al. Front Oncol. .

Abstract

Background: To evaluate the preoperative predictive value of radiomics in the diagnosis of breast cancer (BC).

Methods: By searching PubMed and Embase libraries, our study identified 19 eligible studies. We conducted a meta-analysis to assess the differential value in the preoperative assessment of BC using radiomics methods.

Results: Nineteen radiomics studies focusing on the diagnostic efficacy of BC and involving 5865 patients were enrolled. The integrated sensitivity and specificity were 0.84 (95% CI: 0.80-0.87, I 2 = 76.44%) and 0.83 (95% CI: 0.78-0.87, I 2 = 81.79%), respectively. The AUC based on the SROC curve was 0.91, indicating a high diagnostic value.

Conclusion: Radiomics has shown excellent diagnostic performance in the preoperative prediction of BC and is expected to be a promising method in clinical practice.

Keywords: breast cancer; cancer prediction; meta-analysis; radiomics; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of literature screening according to PRISMA. PRISMA, Preferred Reported Items for Systematic Reviews and Metaanalyses.
Figure 2
Figure 2
Methodological quality of the studies included in the meta-analysis according to the QUADAS 2 tool for risk of bias and applicability concerns. Green, yellow, and red circles represent low, unclear, and high risk of bias, respectively. (A) Individual studies, (B) summary.
Figure 3
Figure 3
Forrest plot of the effect size calculated as log odds ratio for 19 studies investigating the diagnostic accuracy of radiomics in the differentiation of BC from breast masses. Numbers are pooled estimates, with 95% confidence intervals (CIs) depicted with horizontal lines. Heterogeneity statistics are shown at bottom right.
Figure 4
Figure 4
Hierarchical summary receiver operating characteristic curve (SROC) plot of diagnostic performance in predicting BC of the included radiomic models. The numbers in circles correspond to the order of the articles in Table 1 .

Similar articles

Cited by

References

    1. Cancer Tomorrow . International Agency for Research on Cancer . Available at: http://gco.iarc.fr/tomorrow/graphicisotype?type=0&population=900&mode=po... (Accessed January 5, 2020).
    1. Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More Than Pictures, They are Data. Radiology (2016) 278:563–77. doi: 10.1148/radiol.2015151169 - DOI - PMC - PubMed
    1. Weind KL, Maier CF, Rutt BK, Moussa M. Invasive Carcinomas and Fibroadenomas of the Breast: Comparison of Microvessel Distributions—Implications for Imaging Modalities. Radiology (1998) 208(2):477–83. doi: 10.1148/radiology.208.2.9680579 - DOI - PubMed
    1. Cerussi A, Shah N, Hsiang D, Durkin A, Butler J, Tromberg BJ. In Vivo Absorption, Scattering, and Physiologic Properties of 58 Malignant Breast Tumors Determined by Broadband Diffuse Optical Spectroscopy. J BioMed Opt (2006) 11(4):044005. doi: 10.1117/1.2337546 - DOI - PubMed
    1. Valdora F, Houssami N, Rossi F, Calabrese M, Tagliafico AS. Rapid Review: Radiomics and Breast Cancer. Breast Cancer Res Treat (2018) 169(2):217–29. doi: 10.1007/s10549-018-4675-4 - DOI - PubMed

Publication types

LinkOut - more resources